Clopidogrel Response Variability and Its Correlation with Early Recurrent Cardiovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention

Pharmacology ◽  
2011 ◽  
Vol 87 (5-6) ◽  
pp. 321-330 ◽  
Author(s):  
Yamin Liu ◽  
Naifeng Liu ◽  
Weilan Li ◽  
Hua Shao
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Cardiovascular Events ◽  
Coronary Intervention ◽  
Response Variability ◽  
Chinese Patients ◽  
Percutaneous Coronary

scholarly journals Correlation between serum free triiodothyronine levels and risk stratification in Chinese patients with acute coronary syndrome receiving percutaneous coronary intervention

2020 ◽  
Vol 48 (9) ◽  
pp. 030006052095718
Author(s):  
Huiying Li ◽  
Chunlin Li ◽  
Yongyi Bai ◽  
Zhao Wang ◽  
Man Li ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Acute Coronary Syndrome ◽  
Risk Stratification ◽  
Cardiovascular Events ◽  
Coronary Intervention ◽  
Chinese Patients ◽  
Free Triiodothyronine ◽  
Serum Free ◽  
Coronary Syndrome ◽  
Percutaneous Coronary

Objective Low serum free triiodothyronine (FT3) levels are associated with the occurrence of coronary heart disease and with the prognosis of cardiovascular diseases. This study aimed to investigate the relationship between FT3 levels and risk stratification in Chinese Han patients with acute coronary syndrome (ACS) receiving percutaneous coronary intervention (PCI) treatment. Methods Plasma FT3 levels and other parameters were measured in 191 patients with ACS who received PCI. The risk of adverse cardiovascular events was assessed using the Age, Creatinine, and Ejection Fraction (ACEF) score. Results FT3 levels were significantly lower in the high-risk group than in the medium- and low-risk groups. Serum FT3 levels were negatively linearly correlated with the ACEF score (r = −0.590). Stepwise regression analysis showed a negative correlation between FT3 levels and the risk of adverse cardiovascular events as measured by the ACEF score (standardized β = −0.261). Conclusion Serum FT3 levels are negatively related to risk stratification in patients with ACS. Serum FT3 levels may be used as a potential predictor for adverse outcomes of patients with ACS undergoing PCI.

Sign in / Sign up

Export Citation Format

Share Document